HomeTagsSGT-003 Gene Therapy

SGT-003 Gene Therapy

European Commission Grants Orphan Drug Designation to SGT-003 for Duchenne Muscular Dystrophy

SGT-003 Gene Therapy: INSPIRE DUCHENNE Phase 3 Study Begins

Solid Biosciences Aligns With FDA on SGT-003 Phase 3 Trial Design for Duchenne Muscular Dystrophy Gene Therapy

Solid Biosciences Announces 2026 Outlook for Clinical Trials of Duchenne Gene Therapy SGT-003

Solid Biosciences Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy

Solid Biosciences Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions

Solid Biosciences Initiates Phase 3 Clinical Trial of SGT-003 Gene Therapy (IMPACT DUCHENNE) in Ambulant Males

Frequently Asked Questions About Solid Biosciences SGT-003 Gene Therapy

Solid Biosciences Plans to Request a Meeting with the FDA in mid-2025 to Discuss Potential Accelerated Approval Pathways for SGT-003

12 Page 1 of 2

Popular

Frequently Asked Questions About Elevidys Used for DMD

Can Ekinci - August 21, 2026

Must Read

Del-Zota SAFARI44 Phase 3 Trial: A New Exon 44 Skipping Study for Duchenne Muscular Dystrophy

RGX-202 Duchenne Gene Therapy Shows NSAA Improvement and Microdystrophin Expression — But Important Biomarker Data Missing

CRISPR GuideX Tool: hfCas12Max in CRISPR-Based Therapeutics

About us

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Latest Articles

Beyond Micro-Dystrophin: Could Full-Length Dystrophin Be the Next Step in DMD Gene Therapy?

Research September 3, 2026 0

Renzhi Han, PhD, at Indiana University is advancing a...

NewBiologix and Synastra Partner to Advance DMD Gene Therapy Manufacturing

Press Releases September 2, 2026 0

A new international collaboration is bringing together biotechnology expertise...

What Is Exon Deletion? Understanding Exon Deletions in Duchenne Muscular Dystrophy

DMD September 2, 2026 0

What is exon deletion, and why does it matter...

Most Popular

Frequently Asked Questions About Elevidys Used for DMD

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

© 2024 - 2026 DMD Warrior. All rights reserved.